CEO, Fifty1 AI Labs | Inka Health (An Onco-Innovations Ltd. Company) | Board Member | University of Toronto | Epidemiology PhD · Paul is CEO of Inka Health (now an Onco-Innovations Ltd company) and sits on the Scientific and Clinical…
Senior Specialist, HR Business Partner - Ford | B.Tech (CSE) | PGPM (HR) · Business Unit HR Manager with an overall experience of 12 Years with around 8 Years into HR Business Partnering in an IT Organization Strategic Partner responsible…
Guideline-recommended screening programs exist for only a few cancer types. Although all these programs are understood to lead to reductions in cancer-related mortality, standard-of-care screening tests vary in accuracy, adherence and…
Omrkni komunitu TicketGenius Clients na Discordu – má už zhruba 96 dalších členů, takže si tam můžeš skvěle poklábosit a užít si bezplatný hlasový a textov
In Module 3 of our CME microlearning series, experts explore the practical implementation of multicancer early detection (MCED) tests in clinical practice. This module provides valuable insights into how these innovations can transform…
By Jessica Lloyd, PhD and Sowmiya Moorthie. Identifying cancers at an earlier stage, when there are more treatment options, often leads to improved survival.